TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
LGND

Ligand Pharmaceuticals Incorporated

Healthcare · Biotechnology

293.30$ -1.2% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Ligand Pharmaceuticals Incorporated (LGND) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,186 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LGND
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
601 602 630 640 662 671 755 1,858 2,106 1,261 1,914 1,802 1,547 1,495 1,186 1,243 1,247 1,362 1,295 1,256 1,274 1,298 1,105 1,076 1.1 763 811 758 769 787 914 866 955 942 905 949 1,477 1,561 1,532 2,186
141 163 175 197 224 237 349 1,480 1,745 871 1,568 1,442 1,183 1,124 831 864 858 501 437 411 432 465 276 244 0.2 264 328 277 254 237 369 312 309 332 309 353 754 832 865 1,457
124 141 11 173 33 202 51 957 116 718 1,429 1,332 1,100 72 739 810 457 48 32 22 23 20 15 5.3 0.1 45 89 28 19 23 50 18 64 72 48 68 139 175 115 1,007
124 141 159 173 202 202 292 1,017 1,112 765 1,501 1,392 1,150 1,070 772 810 795 411 339 302 323 341 204 148 0.2 212 283 219 191 170 311 227 220 256 209 255 665 734 779 1,358
9.8 18 7.1 17 16 26 41 42 47 56 27 20 22 42 47 45 33 59 56 63 71 92 42 63 0.1 35 29 28 36 39 28 37 42 42 43 42 58 61 55 70
4.0 1.9 7.6 6.8 5.0 4.4 11 9.5 8.1 7.1 12 9.6 6.6 7.3 7.3 3.7 13 26 37 40 33 27 26 25 0.0 13 14 27 25 24 21 14 13 14 12 13 12 9.1 13 10
1.8 1.8 1.9 1.9 3.5 4.2 4.1 4.2 4.4 5.4 5.6 6.3 6.4 7.2 6.7 7.9 7.2 14 17 24 19 33 25 31 33 27 12 11 – – – – – – – – – – – –
280 277 72 271 72 315 86 308 86 306 303 301 310 95 301 319 327 190 191 191 190 106 181 710 0.2 106 440 106 104 103 105 105 105 105 102 102 102 102 102 102
233 26 228 23 220 20 245 20 237 31 31 40 35 231 10 11 11 606 594 583 573 387 550 10 0.5 353 10 336 321 300 291 283 275 267 258 250 234 422 411 209
230 231 231 231 238 252 257 1,238 1,406 700 834 760 697 728 524 548 550 653 549 470 462 476 312 274 0.2 165 165 93 101 86 107 91 114 111 110 120 527 543 535 1,218
226 227 227 226 232 239 247 633 793 82 187 109 36 17 20 31 42 100 96 52 36 42 43 168 0.1 99 99 29 16 17 18 19 25 37 59 65 31 37 41 47
210 213 216 219 222 228 228 210 213 26 28 28 0.9 1.3 1.5 1.7 1.0 8.5 7.6 2.3 2.2 1.4 1.9 118 2.4 77 77 0.7 0.5 0.4 1.0 1.2 1.1 1.3 0.9 1.1 1.1 1.1 1.1 1.1
2.8 2.7 6.5 1.8 3.6 2.3 3.4 2.7 1.6 4.2 5.1 2.9 15 2.4 3.4 19 25 3.8 9.5 17 7.2 8.4 7.0 19 0.0 5.3 6.1 9.6 2.5 2.4 1.9 1.8 4.7 5.2 5.4 8.6 28 3.2 5.3 9.4
0.0 0.0 0.0 0.0 0.0 0.0 0.0 596 603 610 617 624 632 639 444 450 455 442 352 315 317 321 177 – – – – – – – – – – – – – 445 446 447 1,127
370 371 399 409 425 419 497 620 700 561 1,080 1,041 851 767 662 695 698 710 746 787 812 821 793 802 0.8 597 646 665 668 701 807 775 841 830 796 829 950 1,017 997 968
-428 -431 -408 -402 -394 -401 -327 -254 -184 -229 437 423 407 400 371 393 386 392 410 441 455 449 469 468 468 451 493 495 485 503 589 537 530 499 457 461 578 608 595 583
23 21 23 23 24 21 25 24 24 21 21 20 19 17 17 17 16 17 17 17 17 17 17 17 17 17 18 18 17 18 18 18 18 19 19 20 20 21 20 22

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?